[Pathogenesis of Parkinson's disease: a possibility of oxidation].
Jiménez-Jiménez
F J
FJ
Departamento de Neurología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid.
Molina
J A
JA
Fernández-Calle
P
P
Cabrera-Valdivia
F
F
D001205:Ascorbic Acid / Q000627:therapeutic use; D002374:Catalase / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000209:etiology; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology; D005260:Female; D005609:Free Radicals / Q000009:adverse effects; D006801:Humans; D008297:Male; D016877:Oxidants / Q000009:adverse effects* / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D013482:Superoxide Dismutase / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D005609:Free Radicals; D016877:Oxidants; D014810:Vitamin E; D002374:Catalase; D013482:Superoxide Dismutase; D001205:Ascorbic Acid; D004298:Dopamine
Patogenia de la enfermedad de Parkinson: posible papel de las reacciones oxidativas.